These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 7962472

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mode of action of RU 486.
    Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P.
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [Abstract] [Full Text] [Related]

  • 3. Mifepristone: a potential contraceptive.
    Heikinheimo O, Archer DF.
    Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST, Thong KJ, Baird DT.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K, Swahn ML, Svalander P, Bygdeman M.
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL, Sweeting VM, Hillier H, Baird DT.
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB, Massai MR, Salvatierra AM, Fuentealba B, Croxatto HD, Lähteenmäki P.
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [Abstract] [Full Text] [Related]

  • 11. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J.
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [Abstract] [Full Text] [Related]

  • 12. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 13. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 14. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M.
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [Abstract] [Full Text] [Related]

  • 15. Antigestogens.
    Baird DT.
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [Abstract] [Full Text] [Related]

  • 16. The use of anti-progesterones as a medical IUD.
    Nieman LK, Loriaux DL.
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [Abstract] [Full Text] [Related]

  • 17. Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle.
    Croxatto HB, Salvatierra AM, Croxatto HD, Fuentealba B.
    Hum Reprod; 1993 Feb; 8(2):201-7. PubMed ID: 8473419
    [Abstract] [Full Text] [Related]

  • 18. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 19. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC, Cartledge TP, Zellmer AW, Merino MJ, Axiotis C, Loriaux DL, Nieman LK.
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [Abstract] [Full Text] [Related]

  • 20. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E.
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.